Chromosome 21 and Down syndrome: from genomics to pathophysiology

The sequence of chromosome 21 was a turning point for the understanding of Down syndrome. Comparative genomics is beginning to identify the functional components of the chromosome and that in turn will set the stage for the functional characterization of the sequences. Animal models combined with genome-wide analytical methods have proved indispensable for unravelling the mysteries of gene dosage imbalance.

[1]  X. Estivill,et al.  The mouse brain transcriptome by SAGE: differences in gene expression between P30 brains of the partial trisomy 16 mouse model of Down syndrome (Ts65Dn) and normals. , 2000, Genome research.

[2]  R. Aebersold,et al.  Gene Expression Analyzed by High-resolution State Array Analysis and Quantitative Proteomics , 2004, Molecular & Cellular Proteomics.

[3]  D. Cox,et al.  Noncoding sequences conserved in a limited number of mammals in the SIM2 interval are frequently functional. , 2004, Genome research.

[4]  Michael A Rogers,et al.  Hair keratin associated proteins: characterization of a second high sulfur KAP gene domain on human chromosome 21. , 2004, The Journal of investigative dermatology.

[5]  X. Estivill,et al.  Murine models for Down syndrome , 2001, Physiology & Behavior.

[6]  D. Cox,et al.  Trisomy 21: Mechanisms and Models * , 1982, Annals of the New York Academy of Sciences.

[7]  Mouse Genome Sequencing Consortium.  Initial sequencing and comparative analysis of the mouse genome , 2002, Nature.

[8]  C. Epstein.  The Consequences of Chromosome Imbalance: The Consequences of Chromosome Imbalance , 1986 .

[9]  William H. Majoros,et al.  A Comparison of Whole-Genome Shotgun-Derived Mouse Chromosome 16 and the Human Genome , 2002, Science.

[10]  P. Hunt,et al.  To err (meiotically) is human: the genesis of human aneuploidy , 2001, Nature Reviews Genetics.

[11]  Ruedi Aebersold,et al.  Gene expression in yeast responding to mating pheromone: Analysis by high-resolution translation state analysis and quantitative proteomics , 2004 .

[12]  D. Gudbjartsson,et al.  A high-resolution recombination map of the human genome , 2002, Nature Genetics.

[13]  Mark Gerstein,et al.  Molecular fossils in the human genome: identification and analysis of the pseudogenes in chromosomes 21 and 22. , 2002, Genome research.

[14]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[15]  J. Lindstrom,et al.  Alternate Stoichiometries of α4β2 Nicotinic Acetylcholine Receptors , 2003 .

[16]  Yoshiyuki Sakaki,et al.  A comprehensive analysis of allelic methylation status of CpG islands on human chromosome 21q. , 2004, Genome research.

[17]  S. Cawley,et al.  Unbiased Mapping of Transcription Factor Binding Sites along Human Chromosomes 21 and 22 Points to Widespread Regulation of Noncoding RNAs , 2004, Cell.

[18]  Ahmad Salehi,et al.  Failed retrograde transport of NGF in a mouse model of Down's syndrome: Reversal of cholinergic neurodegenerative phenotypes following NGF infusion , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. V. Jongeneel,et al.  Numerous potentially functional but non-genic conserved sequences on human chromosome 21 , 2002, Nature.

[20]  J. Milunsky,et al.  Genetic Disorders and the Fetus , 1988 .

[21]  W. Kuo,et al.  Detection of aneuploidy involving chromosomes 13, 18, or 21, by fluorescence in situ hybridization (FISH) to interphase and metaphase amniocytes. , 1991, American journal of human genetics.

[22]  M. Dierssen,et al.  Impaired short- and long-term memory in Ts65Dn mice, a model for Down syndrome , 1998, Neuroscience Letters.

[23]  J T Richtsmeier,et al.  Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse. , 2000, Human molecular genetics.

[24]  C. Epstein,et al.  Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Reeves,et al.  Global disruption of the cerebellar transcriptome in a Down syndrome mouse model. , 2003, Human molecular genetics.

[26]  Jonathan Pevsner,et al.  Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain. , 2003, Genomics.

[27]  Ajay N. Jain,et al.  Assembly of microarrays for genome-wide measurement of DNA copy number , 2001, Nature Genetics.

[28]  M. Oshimura,et al.  Mice containing a human chromosome 21 model behavioral impairment and cardiac anomalies of Down's syndrome. , 2001, Human molecular genetics.

[29]  Gregor Eichele,et al.  Human chromosome 21 gene expression atlas in the mouse , 2002, Nature.

[30]  A. Aguzzi,et al.  Impaired Differentiation of Schwann Cells in Transgenic Mice with Increased PMP22 Gene Dosage , 1996, The Journal of Neuroscience.

[31]  E. Niebuhr,et al.  Down's syndrome , 1974, Humangenetik.

[32]  S. Antonarakis,et al.  Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome. , 2004, Genome research.

[33]  C. T. Morgan,et al.  A genomic rearrangement resulting in a tandem duplication is associated with split hand-split foot malformation 3 (SHFM3) at 10q24. , 2003, Human molecular genetics.

[34]  Pascal Kahlem,et al.  A gene expression map of human chromosome 21 orthologues in the mouse , 2002, Nature.

[35]  M. Farrer,et al.  Heterotrisomy, a significant contributing factor to ventricular septal defect associated with Down syndrome? , 2000, Human Genetics.

[36]  Alexandre Reymond,et al.  Chromosome 21: a small land of fascinating disorders with unknown pathophysiology. , 2002, The International journal of developmental biology.

[37]  D. Mccormick.  Sequence the Human Genome , 1986, Bio/Technology.

[38]  Bradley P. Coe,et al.  A tiling resolution DNA microarray with complete coverage of the human genome , 2004, Nature Genetics.

[39]  International Human Genome Sequencing Consortium.  Initial sequencing and analysis of the human genome , 2001, Nature.

[40]  J. Schouten,et al.  Rapid, high throughput prenatal detection of aneuploidy using a novel quantitative method (MLPA) , 2003, Journal of medical genetics.

[41]  P. Simpson,et al.  The choice of cell fate in the epidermis of Drosophila , 1991, Cell.

[42]  H. Vijverberg,et al.  Four Pharmacologically Distinct Subtypes of α4β2 Nicotinic Acetylcholine Receptor Expressed in Xenopus laevisOocytes , 1998 .

[43]  J. Delabar,et al.  Molecular Mapping of Twenty-Four Features of Down Syndrome on Chromosome 21 , 1993, European journal of human genetics : EJHG.

[44]  J. Lupski,et al.  Molecular mechanisms for genomic disorders. , 2003, Annual review of genomics and human genetics.

[45]  T. Heffernan,et al.  Partial IFN-alpha/beta and IFN-gamma receptor knockout trisomy 16 mouse fetuses show improved growth and cultured neuron viability. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[46]  G. Edelman,et al.  Kinetics of homophilic binding by embryonic and adult forms of the neural cell adhesion molecule. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[47]  T. Wiltshire,et al.  Use of comparative physical and sequence mapping to annotate mouse chromosome 16 and human chromosome 21. , 2001, Genomics.

[48]  L. Nadel,et al.  The neuropsychology of Down syndrome: evidence for hippocampal dysfunction. , 2003, Child development.

[49]  E. Birney,et al.  Comparison of human chromosome 21 conserved nongenic sequences (CNGs) with the mouse and dog genomes shows that their selective constraint is independent of their genic environment. , 2004, Genome research.

[50]  Katheleen Gardiner,et al.  Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions. , 2003, Gene.

[51]  M. Lovett,et al.  Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[52]  K. Struhl,et al.  The gradient morphogen bicoid is a concentration-dependent transcriptional activator , 1989, Cell.

[53]  C J Epstein,et al.  Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.

[54]  S. Antonarakis,et al.  Cell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Shinsei Minoshima,et al.  A cluster of 21 keratin-associated protein genes within introns of another gene on human chromosome 21q22.3. , 2004, Genomics.

[56]  Mark J Alkema,et al.  Transformation of axial skeleton due to overexpression of bmi-1 in transgenic mice , 1995, Nature.

[57]  C. Epstein,et al.  Genetic Dissection of Region Associated with Behavioral Abnormalities in Mouse Models for Down Syndrome , 2000, Pediatric Research.

[58]  E. Kirkness,et al.  The Dog Genome: Survey Sequencing and Comparative Analysis , 2003, Science.

[59]  S. Cawley,et al.  Novel RNAs identified from an in-depth analysis of the transcriptome of human chromosomes 21 and 22. , 2004, Genome research.

[60]  R. Bronson,et al.  A mouse model for Down syndrome exhibits learning and behaviour deficits , 1995, Nature Genetics.

[61]  Nancy F. Hansen,et al.  Comparative analyses of multi-species sequences from targeted genomic regions , 2003, Nature.

[62]  B. Oostra,et al.  A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. , 2003, Human molecular genetics.

[63]  K. Gardiner,et al.  The sequence of human chromosome 21 and implications for research into Down syndrome , 2000, Genome Biology.

[64]  M. Tymms,et al.  Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice , 1996, Nature.

[65]  L. Shaffer,et al.  Parental origin and timing of de novo Robertsonian translocation formation. , 2002, American journal of human genetics.

[66]  L. Hartwell,et al.  Normal stoichiometry of histone dimer sets is necessary for high fidelity of mitotic chromosome transmission , 1986, Cell.

[67]  M. Adams,et al.  Recent Segmental Duplications in the Human Genome , 2002, Science.

[68]  S. Antonarakis.  10 years of Genomics, chromosome 21, and Down syndrome. , 1998, Genomics.

[69]  D. Albertson,et al.  Chromosome aberrations in solid tumors , 2003, Nature Genetics.

[70]  C. V. Jongeneel,et al.  Nineteen additional unpredicted transcripts from human chromosome 21. , 2002, Genomics.

[71]  J. Bailey,et al.  Patterns of meiotic recombination on the long arm of human chromosome 21. , 2000, Genome research.

[72]  M. Hayden,et al.  Human ABCA1 BAC Transgenic Mice Show Increased High Density Lipoprotein Cholesterol and ApoAI-dependent Efflux Stimulated by an Internal Promoter Containing Liver X Receptor Response Elements in Intron 1* , 2001, The Journal of Biological Chemistry.

[73]  X. Estivill,et al.  A high-resolution physical map of human chromosome 21p using yeast artificial chromosomes. , 1999, Genome research.

[74]  S. P. Fodor,et al.  Large-Scale Transcriptional Activity in Chromosomes 21 and 22 , 2002, Science.

[75]  E. Zackai,et al.  Down syndrome congenital heart disease: A narrowed region and a candidate gene , 2001, Genetics in Medicine.

[76]  Alexandre Reymond,et al.  Evolutionary Discrimination of Mammalian Conserved Non-Genic Sequences (CNGs) , 2003, Science.

[77]  Anne-Marie Chang,et al.  Functional Identification of the Mouse Circadian Clock Gene by Transgenic BAC Rescue , 1997, Cell.

[78]  C. Disteche,et al.  Down syndrome phenotypes: the consequences of chromosomal imbalance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[79]  C. Epstein.  Mechanisms of the effects of aneuploidy in mammals. , 1988, Annual review of genetics.

[80]  K. Gardiner,et al.  Evolutionary breakpoints on human chromosome 21. , 2001, Genomics.

[81]  C. Readhead,et al.  Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage , 1994, Neuron.

[82]  M T Davisson,et al.  Segmental trisomy as a mouse model for Down syndrome. , 1993, Progress in clinical and biological research.

[83]  M. Hattori,et al.  The DNA sequence of human chromosome 21 , 2000, Nature.

[84]  M. Davisson,et al.  Motor dysfunction in a mouse model for Down syndrome , 1999, Physiology & Behavior.

[85]  C. Epstein.  The Consequences of Chromosome Imbalance: Principles, Mechanisms, and Models , 1986 .

[86]  A. C. Chinault,et al.  Charcot–Marie–Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit , 1992, Nature Genetics.

[87]  C. Sismani,et al.  Measurement of locus copy number by hybridisation with amplifiable probes. , 2000, Nucleic acids research.

[88]  Jérôme Lejeune,et al.  Etude des chromosomes somatiques de neuf enfants mongoliens. , 1959 .

[89]  N. Hastie,et al.  Transcriptome analysis of human autosomal trisomy. , 2002, Human molecular genetics.

[90]  R G Worton,et al.  Human ribosomal RNA genes: orientation of the tandem array and conservation of the 5' end. , 1988, Science.

[91]  S. Malcolm,et al.  Proteolipid protein gene dosage effect in Pelizaeus–Merzbacher disease , 1994, Nature Genetics.

[92]  J T Richtsmeier,et al.  Parallels of craniofacial maldevelopment in down syndrome and Ts65Dn mice , 2000, Developmental dynamics : an official publication of the American Association of Anatomists.

[93]  S. P. Fodor,et al.  Blocks of Limited Haplotype Diversity Revealed by High-Resolution Scanning of Human Chromosome 21 , 2001, Science.

[94]  M. Hattori,et al.  DNA sequence and comparative analysis of chimpanzee chromosome 22 , 2004, Nature.

[95]  S. South,et al.  Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome. , 2004, Genome research.

[96]  S. Antonarakis,et al.  Mice trisomic for a bacterial artificial chromosome with the single-minded 2 gene (Sim2) show phenotypes similar to some of those present in the partial trisomy 16 mouse models of Down syndrome. , 2000, Human molecular genetics.

[97]  A. Reymond,et al.  From PREDs and open reading frames to cDNA isolation: revisiting the human chromosome 21 transcription map. , 2001, Genomics.